Securities Registration: Employee Benefit Plan (s-8)
October 28 2022 - 4:27PM
Edgar (US Regulatory)
As
filed with the Securities and Exchange Commission on October 28, 2022
Registration
No. 333-_______
United
States
SECURITIES
AND EXCHANGE cOMMISSION
Washington,
D.C. 20549
fOrm
S-8
registration
statement
under
the securities act of 1933
Xtant
Medical holdings, Inc.
(Exact
name of registrant as specified in its charter)
Delaware |
20-5313323 |
(State
or other jurisdiction of
incorporation or organization) |
(I.R.S.
Employer
Identification No.) |
664
Cruiser Lane
Belgrade,
Montana
|
59714
|
(Address
of Principal Executive Offices) |
(Zip
Code) |
Xtant
Medical Holdings, Inc. Second Amended and Restated
2018
Equity Incentive Plan
(Full
title of the plan)
Sean
E. Browne
President
and Chief Executive Officer
Xtant
Medical Holdings, Inc.
664
Cruiser Lane
Belgrade,
Montana 59714
(Name
and address of agent for service)
(406)
388-0480
(Telephone
number, including area code, of agent for service)
Copies
requested to:
Amy
E. Culbert, Esq.
Emily
Humbert, Esq.
Fox
Rothschild LLP
222
South Ninth Street, Suite 2000
Minneapolis,
Minnesota 55402-3338
(612)
607-7000
Indicate
by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting
company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,”
“smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
|
Large
accelerated filer |
☐ |
Accelerated
filer ☐ |
|
Non-accelerated
filer |
☒ |
Smaller
reporting company ☒ |
|
|
|
Emerging
growth company ☐ |
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐
EXPLANATORY
NOTE
This
Registration Statement on Form S-8 (the “Registration Statement”) of Xtant Medical Holdings, Inc. (the “Company”
or the “Registrant”) is being filed pursuant to General Instruction E to Form S-8 under the Securities Act of 1933, as amended
(the “Securities Act”), to register an additional 8,500,000 shares of the Company’s common stock, par value $0.000001
per share (the “Common Stock”), available for issuance under the Xtant Medical Holdings, Inc. Second Amended and Restated
2018 Equity Incentive Plan (such plan and all prior and subsequent versions thereof, the “2018 Plan”). This share increase
was approved by the Company’s stockholders at an annual meeting of stockholders held on October 26, 2022. The Company previously
filed with the Securities and Exchange Commission (the “SEC”) a Registration Statement on Form S-8 (Reg. No. 333-226588)
to register the initial 1,307,747 shares of Common Stock available for issuance under the 2018 Plan, a Registration Statement on Form
S-8 (Reg. No. 333-234595) to register an additional 1,500,000 shares of Common Stock available for issuance under the 2018 Plan, and
a Registration Statement on Form S-8 (Reg. No. 333-249762) to register an additional 5,550,308 shares of Common Stock available for issuance
under the 2018 Plan. The contents of such prior Registration Statements, with the exception of Items 3 and 8 of Part II of such prior
Registration Statements, are hereby incorporated by reference.
PART
II
Information
Required In The Registration Statement
Item
3. Incorporation of Documents by Reference.
The
Company hereby incorporates by reference into this Registration Statement the following documents, which have been previously filed (not
furnished) with the SEC:
| (a) | The
Company’s Annual Report on Form 10-K for the year ended December 31, 2021 filed with the SEC on March 8, 2022 (File No. 001-34951); |
| | |
| (b) | The
Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2022 filed with the SEC on May 5, 2022 and the Company’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2022 filed with the SEC on August 4, 2022 (File No. 001-34951); |
| | |
| (c) | The
Company’s Current Reports on Form
8-K (other than portions thereof furnished under Item 2.02 or Item 7.01 of Form 8-K and exhibits accompanying such reports that
are related to such items) filed with the SEC on January
3, 2022, May
2, 2022, August
24, 2022, August
31, 2022, October
11, 2022 and October 28, 2022 (File No. 001-34951); |
| | |
| (d) | The
Company’s Definitive Proxy Statement on Schedule 14A for the Company’s 2022 Annual Meeting of Stockholders filed with the SEC on September 20, 2022 (File No. 001-34951); and |
| | |
| (e) | The
description of the Common Stock contained in the Company’s Registration Statement on
Form 8-A, filed on October 15, 2015, as amended March 8, 2022, including any amendment or
reports filed for the purpose of updating such description (File No. 001-34951). |
In
addition, all other documents filed (not furnished) by the Company pursuant to Section 13(a), Section 13(c), Section 14, or Section 15(d)
of the Securities Exchange Act of 1934, as amended, on or after the date of this Registration Statement and prior to the filing of a
post-effective amendment to this Registration Statement that indicates that all securities offered hereby have been sold or that deregisters
all securities then remaining unsold shall be deemed to be incorporated in this Registration Statement by reference and to be a part
of this Registration Statement from the date of filing of such documents; provided, however, that documents or information
deemed to have been furnished to and not filed with the SEC in accordance with the rules of the SEC shall not be deemed incorporated
by reference into this Registration Statement.
Any
statement contained in a document incorporated or deemed to be incorporated by reference herein shall be deemed to be modified or superseded
for purposes of this Registration Statement to the extent that a statement contained herein or in any subsequently filed document which
also is deemed to be incorporated by reference herein modifies or supersedes such statement. Any such statement so modified or superseded
shall not be deemed, except as so modified or superseded, to constitute a part of this Registration Statement.
Item
8. Exhibits.
The
following exhibits are filed with or incorporated by reference into this Registration Statement:
Exhibit
No. |
|
Description |
|
|
|
3.1 |
|
Amended and Restated Certificate of Incorporation of Xtant Medical Holdings, Inc. (filed as Exhibit 3.1 to the Registrant’s Current Report on Form 8-K filed with the SEC on February 13, 2018 (SEC File No. 001-34951) and incorporated by reference herein) |
|
|
|
3.2 |
|
Certificate of Amendment of the Amended and Restated Certificate of Incorporation of Xtant Medical Holdings, Inc. (filed as Exhibit 3.1 to the Registrant’s Current Report on Form 8-K filed with the SEC on October 31, 2019 (SEC File No. 001-34951) and incorporated by reference herein) |
|
|
|
3.3 |
|
Certificate of Amendment of the Amended and Restated Certificate of Incorporation of Xtant Medical Holdings, Inc. (filed as Exhibit 3.1 to the Registrant’s Current Report on Form 8-K filed with the SEC on October 1, 2020 (SEC File No. 001-34951) and incorporated by reference herein) |
|
|
|
3.4 |
|
Second Amended and Restated Bylaws of Xtant Medical Holdings, Inc. (filed as Exhibit 3.1 to the Registrant’s Current Report on Form 8-K filed with the SEC on February 16, 2018 (SEC File No. 001-34951) and incorporated by reference herein) |
|
|
|
4.1 |
|
Form of Common Stock Certificate of Xtant Medical Holdings, Inc. (filed as Exhibit 4.2 to the Registrant’s Annual Report on Form 10-K for the year ended December 31, 2021 (SEC File No. 001-34951) and incorporated by reference herein) |
|
|
|
5.1 |
|
Opinion of Fox Rothschild LLP regarding the validity of the shares of Common Stock being registered (filed herewith) |
|
|
|
23.1 |
|
Consent of Plante & Moran, PLLC (filed herewith) |
|
|
23.2 |
|
Consent of Fox Rothschild LLP (included within the opinion filed as Exhibit 5.1) |
|
|
24.1 |
|
Power of Attorney (included on signature page to this Registration Statement) |
|
|
|
99.1 |
|
Xtant Medical Holdings, Inc. Second Amended and Restated 2018 Equity Incentive Plan (filed as Exhibit 10.1 to the Registrant’s Current Report on Form 8-K filed with the SEC on October 28, 2022 (SEC File No. 001-34951) and incorporated by reference herein) |
|
|
|
107 |
|
Filing Fee Table (filed herewith) |
Signatures
Pursuant
to the requirements of the Securities Act of 1933, as amended, the Registrant certifies that it has reasonable grounds to believe that
it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by
the undersigned, thereunto duly authorized, in the City of Belgrade, State of Montana, on October 28, 2022.
|
XTANT MEDICAL
HOLDINGS, INC. |
|
|
|
|
By: |
/s/
Sean E. Browne |
|
|
Sean E. Browne |
|
|
President and Chief Executive
Officer |
POWER
OF ATTORNEY
KNOW
ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Stavros Vizirgianakis, Sean Browne
and Scott Neils, and each of them, as his true and lawful attorneys-in-fact and agents, with full power of substitution for him in any
and all capacities, to sign (i) any and all amendments (including post-effective amendments) to this Registration Statement and (ii)
any registration statement or post-effective amendment thereto to be filed with the Securities and Exchange Commission pursuant to Rule
462(b) under the Securities Act of 1933, as amended, and to file the same, with all exhibits thereto, and other documents in connection
therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power
and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith, as fully to
all intents and purposes as he might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents,
or any of them, or their or his substitute or substitutes, may lawfully do or cause to be done by virtue hereof.
Pursuant
to the requirements of the Securities Act of 1933, as amended, this Registration Statement has been signed by the following persons in
the capacities and on the dates indicated.
Name
and Signature |
|
Title |
|
Date |
|
|
|
|
|
/s/
Sean E. Browne |
|
President
and Chief Executive Officer and Director |
|
October
28, 2022 |
Sean E. Browne |
|
(principal executive officer) |
|
|
|
|
|
|
|
/s/
Scott Neils |
|
Chief
Financial Officer |
|
October
28, 2022 |
Scott Neils |
|
(principal financial and accounting officer) |
|
|
|
|
|
|
|
/s/
Stavros Vizirgianakis |
|
Chairman of the Board |
|
October
28, 2022 |
Stavros Vizirgianakis |
|
|
|
|
|
|
|
|
|
/s/
John Bakewell |
|
Director |
|
October
28, 2022 |
John Bakewell |
|
|
|
|
|
|
|
|
|
/s/
Michael Eggenberg |
|
Director |
|
October
28, 2022 |
Michael Eggenberg |
|
|
|
|
|
|
|
|
|
/s/
Robert McNamara |
|
Director |
|
October
28, 2022 |
Robert McNamara |
|
|
|
|
|
|
|
|
|
/s/
Matthew Rizzo |
|
Director |
|
October 28, 2022 |
Matthew Rizzo |
|
|
|
|
Xtant Medical (AMEX:XTNT)
Historical Stock Chart
From Mar 2024 to Apr 2024
Xtant Medical (AMEX:XTNT)
Historical Stock Chart
From Apr 2023 to Apr 2024